118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis

F Zehentmayr; B Grambozov; J Karner; E Ruznic; C Gaisberger; G Fastner; B Zellinger; R Moosbrugger; Michael Studnicka; F Sedlmayer; M Stana

118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis

F Zehentmayr, B Grambozov, J Karner, E Ruznic, C Gaisberger, G Fastner, B Zellinger, R Moosbrugger, Michael Studnicka, F Sedlmayer, M Stana

Universitätsklinik für Pneumologie

Publikation: Konferenzbeitrag › nicht-publizierter Abstrakt

Originalsprache	Englisch
Publikationsstatus	Veröffentlicht - 2023
Veranstaltung	European Lung Cancer Congress 2023 - Copenhagen, Denmark, Dänemark Dauer: 29 März 2023 → 1 Apr. 2023

Konferenz mit wissenschaftlichem Inhalt

Konferenz mit wissenschaftlichem Inhalt	European Lung Cancer Congress 2023
Land/Gebiet	Dänemark
Ort	Copenhagen, Denmark
Zeitraum	29/03/23 → 1/04/23

Zugriff auf Dokument

https://doi.org/10.1016/S1556-0864(23)00373-8

1 Poster

118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis
Zehentmayr, F., Grambozov, B., Karner, J., Ruznic, E., Gaisberger, C., Fastner, G., Zellinger, B., Moosbrugger, R., Studnicka, M., Sedlmayer, F. & Stana, M., 2023.
Publikation: Konferenzbeitrag › Poster

Dieses zitieren

Zehentmayr, F., Grambozov, B., Karner, J., Ruznic, E., Gaisberger, C., Fastner, G., Zellinger, B., Moosbrugger, R., Studnicka, M., Sedlmayer, F., & Stana, M. (2023). 118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis. Abstract von European Lung Cancer Congress 2023, Copenhagen, Denmark, Dänemark. https://doi.org/10.1016/S1556-0864(23)00373-8

@conference{99dc98e1d0b84677843ecacee087dd07,

title = "118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis",

author = "F Zehentmayr and B Grambozov and J Karner and E Ruznic and C Gaisberger and G Fastner and B Zellinger and R Moosbrugger and Michael Studnicka and F Sedlmayer and M Stana",

year = "2023",

language = "English",

note = "European Lung Cancer Congress 2023 ; Conference date: 29-03-2023 Through 01-04-2023",

}

Zehentmayr, F, Grambozov, B, Karner, J, Ruznic, E, Gaisberger, C, Fastner, G, Zellinger, B, Moosbrugger, R, Studnicka, M, Sedlmayer, F & Stana, M 2023, '118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis', European Lung Cancer Congress 2023, Copenhagen, Denmark, Dänemark, 29/03/23 - 1/04/23. <https://doi.org/10.1016/S1556-0864(23)00373-8>

TY - CONF

T1 - 118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis

AU - Zehentmayr, F

AU - Grambozov, B

AU - Karner, J

AU - Ruznic, E

AU - Gaisberger, C

AU - Fastner, G

AU - Zellinger, B

AU - Moosbrugger, R

AU - Studnicka, Michael

AU - Sedlmayer, F

AU - Stana, M

PY - 2023

Y1 - 2023

M3 - unpublished Abstract

T2 - European Lung Cancer Congress 2023

Y2 - 29 March 2023 through 1 April 2023

ER -

118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis

Konferenz mit wissenschaftlichem Inhalt

Zugriff auf Dokument

Publikationen

118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis

Dieses zitieren